Journal
NEUROSCIENCE BULLETIN
Volume 32, Issue 3, Pages 227-238Publisher
SPRINGER
DOI: 10.1007/s12264-016-0034-9
Keywords
Alzheimer's disease; Insulin resistance; Ab peptides; Insulin signaling; Cholesterol synthesis pathway; Pro-inflammatory response
Categories
Funding
- CIHR [109606, 106886, TAD 125698]
- University of Ottawa
Ask authors/readers for more resources
Alzheimer's disease (AD) is characterized by amyloid-beta (A beta) toxicity, tau pathology, insulin resistance, neuroinflammation, and dysregulation of cholesterol homeostasis, all of which play roles in neurodegeneration. Insulin has polytrophic effects on neurons and may be at the center of these pathophysiological changes. In this study, we investigated possible relationships among insulin signaling and cholesterol biosynthesis, along with the effects of A beta(42) on these pathways in vitro. We found that neuroblastoma 2a (N2a) cells transfected with the human gene encoding amyloid-beta protein precursor (A beta PP) (N2a-A beta PP) produced A beta and exhibited insulin resistance by reduced p-Akt and a suppressed cholesterol-synthesis pathway following insulin treatment, and by increased phosphorylation of insulin receptor subunit-1 at serine 612 (p-IRS-S612) as compared to parental N2a cells. Treatment of human neuroblastoma SH-SY5Y cells with A beta(42) also increased p-IRS-S612, suggesting that A beta(42) is responsible for insulin resistance. The insulin resistance was alleviated when N2a-A beta PP cells were treated with higher insulin concentrations. Insulin increased A beta release from N2a-A beta PP cells, by which it may promote A beta clearance. Insulin increased cholesterol-synthesis gene expression in SH-SY5Y and N2a cells, including 24-dehydrocholesterol reductase (DHCR24) and 3-hydroxy-3-methyl-glutaryl-CoA reductase (HMGCR) through sterol-regulatory element-binding protein-2 (SREBP2). While A beta(42)-treated SH-SY5Y cells exhibited increased HMGCR expression and c-Jun phosphorylation as pro-inflammatory responses, they also showed down-regulation of neuro-protective/anti-inflammatory DHCR24. These results suggest that A beta(42) may cause insulin resistance, activate JNK for c-Jun phosphorylation, and lead to dysregulation of cholesterol homeostasis, and that enhancing insulin signaling may relieve the insulin-resistant phenotype and the dysregulated cholesterol-synthesis pathway to promote A beta release for clearance from neural cells.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available